Inventor · disambiguated record
Jiankai Liang
Also filed as: LIANG JIANKAI
4 granted patents·3 pending applications·2 citations·filing 2015–2019
60Inventor score
Top patents by PatentIndex Score
7 records- 0175US11234968B2Use of VCP inhibitor and oncolytic virus in the preparation of an anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Feb 1, 2022·1 cites·12 claims
- 0268US10517909B2Use of alphavirus in preparation of antitumor drugsGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2015·Granted Dec 31, 2019·1 cites·45 claims
- 0358US11235011B2Use of alphavirus in preparation of antitumor drugsGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 1, 2022·0 cites·20 claims
- 0453US10980850B2Use of IAP inhibitor and oncolytic virus in preparation of anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Apr 20, 2021·0 cites·13 claims
- 0546US2021228660A1Use of proteasome inhibitor and alphavirus in preparation of anti-tumor medicamentGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 0643US2020405793A1Use of mevalonate metabolic pathway inhibitor and alphavirus in preparing anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 0741US2019183948A1Use of bcl-xl inhibitor and oncolytic virus in preparation of antitumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiankai Liang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →